Primary outcome: Percentage change in body weight and the proportion of participants who lost at least 5% of baseline weight by week 68 Results: Primary outcome (% weight loss): Wegovy - 16%, Placebo - 5.7% (p 35 - 68.9% Randomized treatment groups Group 1 (374 patients): Tirzepatide titrated to the maximum tolerated dose of 10 mg or 15 mg once weekly Group 2 (376 patients): Semaglutide titrated to the maximum tolerated dose of 1.7 mg or 2.4 mg once weekly Tirzepatide was initiated at a dose of 2.5 mg once weekly, and the dose was increased by 2.5 mg every 4 weeks until a maximum tolerated dose of 10 mg or 15 mg was reached
Serious but rare risks include pancreatitis, gallbladder disease, and hypoglycaemia (particularly when used with insulin or sulfonylureas)
This makes GLP-1 Elevate a more accessible, needle-free option for those looking to avoid invasive treatment
Before you use "GLP-1 Compounding Pharmacies: Everything You Need to Know Before Buying" to make a real decision, separate the headline answer from the details that could change it
3 Can You Lose Weight by Taking Psyllium Husk
Superior Stability The acetylation process protects SAG from premature breakdown, ensuring more effective delivery